CLINICAL PHARMACOKINETICS CONCEPTS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS OF PHYTOMEDICINES IN SOME DEVELOPING COUNTRIES

Journal Title: World Journal of Pharmaceutical and life sciences - Year 2018, Vol 4, Issue 7

Abstract

Clinical Pharmacokinetics can be defined as the study of the relationship between drug dosage regimens and the concentration time profiles. There has been in the last decades a significant progress in the field of Clinical Pharmacokinetics (CPK) in the drug development process and the understanding of the ethical and regulatory demands within the pharmaceutical industries. The three basic parameters that govern PK relationships are Clearance i.e. the volume of the blood that is cleared out completely of the drug per unit time, Distribution volume i.e. the apparent volume in which the drug has been distributed to make the measured concentration and half-life i.e. the time that is required for 50 percent of the drug to be completely eradicated. The knowledge of clearance can be useful in calculating the dose rate needed to retain a target concentration. In addition, elimination half-time helps in determining the time needed for a drug to be completely eliminated from the body. It also indicates the time taken to attain a steady state and can be further used to determine the optimum dosage interval for producing the target peak to trough. On similar lines, essential advancement has been made in the rational design of quinine dosage regimens for patients in places such as Africa and South East Asia. This review paper attempts to discuss ethical issues in clinical Pharmacokinetics in the development of new drugs for poverty related diseases in developing economies. The paper attempts to give an overview of the effect of pharmacokinetics as a factor on therapeutic failure, and how PK can support therapeutic drug monitoring in a clinical setting and its relevance in herbal medicines research. The ethical issues involving PK studies have been discussed.

Authors and Affiliations

Tembe Fokunang E. A.

Keywords

Related Articles

EVALUATION OF FIBER RICH DIETS IN LIPID MANAGEMENT OF HUMAN TYPE II DIABETES MELLITIS

Objective: This study is designed to evaluate the effects of fiber in lipid management (blood level of cholesterol, triglyceride, HDL, LDL, VLDL, RR) of human Type II Diabetes Mellitus. Method: Under this study three die...

CHRONIC AMEBIASIS [ENTAMOEBA HISTOLYTICA]: DETECTION BY IMMUNODIAGNOSIS METHOD

Enzyme immunoassay (EIA) kits for Entamoeba histolytica antibody detection are commercially available. Antibody detection is most useful in patients with extra intestinal disease (amebic liver abscess) when organisms are...

USE OF CAD/CAM TECHNOLOGY IN DENTAL IMPLANT

Despite the predictable longevity of implant prosthesis, there is an ongoing interest to continue to improve implant prosthodontic treatment and outcomes. One of the developments is the application of computer-aided desi...

FORMULATION AND EVALUATION OF ANTIFUNGAL GEL FROM ETHANOLIC EXTRACT OF TECTONA GRANDIS

The objective of the present investigation was to develop and evaluate antifungal gel from ethanolic extract of Tectona grandis. The frontal leaves of Tectona grandis (Verabenaceae) are widely used in the folklore to tre...

OUR EXPERIENCE IN LAPAROSCOPIC CHOLECYSTECTOMY: A RETROSPECTIVE STUDY

Introduction: Cholecystectomy is the surgical resection of the gallbladder and is one of the most routinely performed surgical procedures by general surgeons all over the world. Surgical options include the newer, standa...

Download PDF file
  • EP ID EP655806
  • DOI -
  • Views 154
  • Downloads 0

How To Cite

Tembe Fokunang E. A. (2018). CLINICAL PHARMACOKINETICS CONCEPTS IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS OF PHYTOMEDICINES IN SOME DEVELOPING COUNTRIES. World Journal of Pharmaceutical and life sciences, 4(7), 22-32. https://europub.co.uk/articles/-A-655806